CFR Pharmaceuticals: Potential Synergies in Africa Harvard Case Solution & Analysis

The leaders of the third generation of CFR Pharmaceuticals proved themselves through the implementation of effective strategies that succeeded to integrate the pharmaceutical firms across the Latin America. The company strategy to focus on globalization, embraced with numerous growth opportunities and from designed course of actions for their strategy the company started acquisition of a South African company, Adcock Ingram.

The executives expected that this move would create synergy and diversification in CFR product and would also improve the company’s supply chain activities with a remarkable presence in 23 countries.

Simultaneously, many of the other potential acquirers bend their focus for the acquisition of Adcock which made a troublesome for CFR as the CEO had made an offer of almost $1.2B for this acquisition. However, multiple other challenges were encountered by the CEO, including when a shareholder became opponent for this acquisition, but the CEO endeavored to retain the confidence of the board of Adcock. The author, Charlene Lew is affiliated with the University of Pretoria.

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.